# A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency

> **NCT01700387** · PHASE4 · COMPLETED · sponsor: **Cady, Roger, M.D.** · enrollment: 20 (actual)

## Conditions studied

- Chronic Migraine

## Interventions

- **DRUG:** onabotulinumtoxinA
- **DRUG:** Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01700387
- **Lead sponsor:** Cady, Roger, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700387, "A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01700387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*